Abstract
In order to further understanding of how different isolates of Burkholderia cepacia complex persist, spread and cause disease, B. cepacia-complex isolates from 60 patients attending the Cystic Fibrosis Centre of Verona, Italy, between 1997 and 2002 were analyzed. Strains were examined for species, presence of putative epidemic and virulence markers (i.e., cblA and the B. cepacia epidemic-strain marker [BCESM]), genetic relatedness and antibiotic susceptibility. Forty-five percent of patients were infected with B. cenocepacia recA subgroup B, 28% with B. cenocepacia recA subgroup A, 5% with B. multivorans and 5% with B. cepacia. No isolate carried cblA but 35% of B. cenocepacia and one of B. cepacia carried the BCESM transmissibility marker. Pulsed-field gel electrophoresis (PFGE) identified 40 types; 22 of these corresponded to sporadic isolates and 18 to clusters of identical or genetically related strains. Piperacillin, ceftazidime and piperacillin-tazobactam were the most active antibiotics (43.3, 31.1 and 35.5% of resistance, respectively). These results confirm the prevalence of B. cenocepacia in cystic fibrosis patients with rapid clinical deterioration and in those with stable cases of infection. The rates of multiple-source and cross infection were relatively low.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Govan JRW, Hughes JE, Vandamme P (1996) Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 45:395–407
Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JRW, Taylor P, Vandamme P (2000) Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38:910–913
Coenye T, Vandamme P, LiPuma JJ, Govan JRW, Mahenthiralingam E (2003) Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol 41:2797–2798
Mahenthiralingam E, Simpson DA, Speert DP (1997) Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 35:808–816
Clode FE, Kaufmann ME, Malnick H, Pitt TL (2000) Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol 38:1763–1766
National Committee for Clinical Laboratory Standards (1999) Performance standards for antimicrobial susceptibility testing. Ninth Informational Supplement. M100-S9. NCCLS, Wayne, Pennsylvania
Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P (2000) DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38:3165–3173
Coenye T, Spilker T, Martin A, LiPuma JJ (2002) Comparative assessment of genoty** methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol 40:3300–3307
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain ty**. J Clin Microbiol 33:2233–2239
LiPuma JJ, Spilker T, Gill LH, Campbell III PW, Liu L, Mahenthiralingam E (2001) Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164:92–96
Kidd TJ, Bell SC, Coulter C (2003) Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit. Eur J Clin Microbiol Infect Dis 22:434–437
Cunha MV, Leitão JH, Mahenthiralingam E, Vandamme P, Lito L, Barreto C, Salgado MJ, Sá-Correia I (2003) Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol 41:4113–4120
Crowley D, Daly M, Lucey B, Shine P, Collins JJ, Cryan B, Moore JE, Murphy P, Buckley G, Fanning S (2002) Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland. J Appl Microbiol 92:992–1004
Bevivino A, Dalmastri C, Tabacchioni S, Chiarini L, Belli ML, Piana S Materazzo A, Vandamme P, Manno G (2002) Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 40:846–851
Petrucca A, Cipriani P, Valenti P, Santapaola D, Cimmino C, Scoarughi GL, Santino I, Stefani S, Sessa R, Nicoletti M (2003) Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Res Microbiol 154:491–498
Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E (2002) Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 8:181–187
McDowell A, Mahenthiralingam E, Dunbar KEA, Moore JE, Crowe M, Elborn JS (2004) Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. J Med Microbiol 53:663–668
Bernhardt SA, Spilker T, Coffey T, LiPuma JJ (2003) Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Clin Infect Dis 37:780–785
Pitt TL, Kaufmann ME, Patel PS, Benge LC, Gaskin S, Livermore DM (1996) Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 44:203–210
Acknowledgements
This work was supported by Italian Cystic Fibrosis Foundation (grant n.4/2002). We thank F. Favari, for providing the strains included in the study and E. Mahenthiralingam for providing reference strains.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Golini, G., Cazzola, G. & Fontana, R. Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre. Eur J Clin Microbiol Infect Dis 25, 175–180 (2006). https://doi.org/10.1007/s10096-006-0099-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-006-0099-x